Furthermore, local intra-tumoural administration of ICI-OVs elicited pronounced systemic increases in activated CD4+ and CD8+ T cells, increased effector memory and central memory T cells and decreased MDSC and Treg populations [75,79,83]. This evidence concerns the gene CD8A and neoplasm.